SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-223992
Filing Date
2023-08-29
Accepted
2023-08-29 17:57:06
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d531716ds3.htm S-3 189358
2 EX-5.1 d531716dex51.htm EX-5.1 10987
3 EX-23.1 d531716dex231.htm EX-23.1 1689
4 EX-FILING FEES d531716dexfilingfees.htm EX-FILING FEES 17100
5 GRAPHIC g531716g26k02.jpg GRAPHIC 30243
6 GRAPHIC g531716g65b23.jpg GRAPHIC 4243
7 GRAPHIC g531716g91i02.jpg GRAPHIC 1915
  Complete submission text file 0001193125-23-223992.txt   270795
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274257 | Film No.: 231223301
SIC: 2834 Pharmaceutical Preparations